Inflammation

Items 211-220 of 270

per page
Set Descending Direction
  1. IL-8 (human):Fc (human) (rec.) (non-lytic)
    CHI-HF-22008
    CHI-HF-22008-C01010 µg
    CHF 170.00
    CHI-HF-22008-C05050 µg
    CHF 300.00
  2. LAG-3 (human):Fc (human) (rec.)
    AG-40B-0031
    AG-40B-0031-C05050 µg
    CHF 395.00
    Binding of LAG-3 (human):Fc (human) (rec.) (Prod. No. AG-40B-0031) on dendritic and B cells. Method: Monocyte-derived immature DC (iDC), DC matured for 48h with LPS (mDC) and EBV-transformed B-cells are incubated with either an anti-
  3. LAG-3 (mouse):Fc (mouse) (rec.)
    AG-40B-0039
    AG-40B-0039-C05050 µg
    CHF 410.00
  4. LIF (human) (rec.)
    AG-40B-0093
    AG-40B-0093-C01010 µg
    CHF 170.00
    AG-40B-0093-30103 x 10 µg
    CHF 335.00
    AG-40B-0093-C100100 µg
    CHF 1'010.00
    Figure: Human Leukemia Inhibitory Factor (LIF) (rec.) (AG-40B-0093) maintains pluripotency of mouse ES cells. Method: Mouse ES oct4 GFP cells were cultured for 3 days in the presence of the indicated concentrations of LIF and followed
  5. LIGHT, Soluble (human) (rec.)
    AG-40B-0009
    AG-40B-0009-C01010 µg
    CHF 145.00
    AG-40B-0009-30103 x 10 µg
    CHF 290.00
  6. LTβR (human):Fc (human) (rec.) (non-lytic)
    CHI-HF-220LTBR
    CHI-HF-220LTBR-C100100 µg
    CHF 420.00
  7. NF-κB (p50) (human) (rec.) (His) (highly active)
    AG-40T-0021
    AG-40T-0021-C0022 µg
    CHF 450.00
  8. NF-κB (p65) (human) (rec.) (His) (highly active)
    AG-40T-0020
    AG-40T-0020-C0022 µg
    CHF 390.00
  9. OX40 (human):Fc (human) (rec.)
    AG-40B-0014
    AG-40B-0014-C05050 µg
    CHF 215.00
    AG-40B-0014-30503 x 50 µg
    CHF 430.00
  10. OX40L (mouse) (multimeric) (rec.)
    AG-40B-0029
    AG-40B-0029-C01010 µg
    CHF 220.00

Items 211-220 of 270

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.